Submission Details
| 510(k) Number | K223852 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 22, 2022 |
| Decision Date | February 24, 2023 |
| Days to Decision | 64 days |
| Submission Type | Special |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K223852 is an FDA 510(k) clearance for the VySpan? PCT System, a Posterior Cervical Screw System (Class II — Special Controls, product code NKG), submitted by Vy Spine, LLC (Tallahassee, US). The FDA issued a Cleared decision on February 24, 2023, 64 days after receiving the submission on December 22, 2022. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3075.
| 510(k) Number | K223852 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 22, 2022 |
| Decision Date | February 24, 2023 |
| Days to Decision | 64 days |
| Submission Type | Special |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | NKG — Posterior Cervical Screw System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3075 |
| Definition | Posterior Cervical Screw Systems Are Intended For Use In Fusion Procedures Of The Cervical Spine And/or Craniocervical Junction And/or Cervicothoracic Junction For: 1) Spinal Fractures And Dislocations; 2) Deformities; 3) Instabilities; 4) Failed Previous Fusions; 5) Tumors; 6) Inflammatory Disorders; 7) Spinal Degeneration, 8) Facet Degeneration With Instability; And 9) Reconstruction Following Decompression To Treat Radiculopathy And/or Myelopathy. These Systems Are Also Intended To Stabilize The Spine In The Absence Of Fusion For A Limited Time Period In Patients With Tumors Involving The Cervical Spine In Whom Life Expectancy Is Of Insufficient Duration To Permit Achievement Of Fusion. |